Dr. Andrew V. Schally
VA Medical Center Miami and University
Biography & Research Background
Andrew V. Schally, PhD, is a Nobel Prize laureate (1977) and Distinguished Medical Research Scientist at the VA Medical Center Miami and University of Miami. He spent decades developing GHRH analogs including agonists and antagonists, with major contributions to understanding oncological applications of GHRH peptides in glioblastoma, lung, and prostate cancer via GHRH receptor downregulation. Andrew V. Schally is being referenced as one of the leading scientists involved in the research and development of Sermorelin. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Andrew V. Schally is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Andrew V. Schally is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.